Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: A meta-analysis of 24 observational studies

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 1911-1919

  Castillo, Jorge J ^a   Dalia, Samir ^b  

^a BROWN UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Meta analysis; Meta regression; Non Hodgkin lymphoma; Smoking

Indexed keywords

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CIGARETTE SMOKING; DISEASE ASSOCIATION; FOLLICULAR LYMPHOMA; GENETIC HETEROGENEITY; HUMAN; LARGE CELL LYMPHOMA; META ANALYSIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; T CELL LYMPHOMA;

CASE-CONTROL STUDIES; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; PROSPECTIVE STUDIES; SMOKING;

EID: 84862512286     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.673225     Document Type: Article

References (51)

1. Surveillance, Epidemiology and End Results. 2011. Available from: http://seer.cancer.gov
2. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int JCancer 2009;125:398-405.
3. Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111:4029-4038.
4. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int JCancer 2008;123:187-194.
5. Seaberg EC, Wiley D, Martinez-Maza O, et al. Cancer incidence in the multicenter AIDSCohort Study before and during the HAARTera: 1984 to 2007. Cancer 2010;116:5507-5516.
6. Morton LM, Wang SS, Cozen W, et al. Etiologic heterog eneity among non-Hodgkin lymphoma subtypes. Blood 2008;112:5150-5160.
7. Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a metaanalysis of observational studies. Blood 2010;116:2897-2907.
8. Besson H, Renaudier P, Merrill RM, et al. Smoking and non-Hodgkin ' s lymphoma: a case-control study in the Rhone-Alpes region of France. Cancer Causes Control 2003;14:381-389.
9. Bracci PM, Holly EA. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California. Cancer Causes Control 2005;16:333-346.
10. Chang CM, Schroeder JC, Olshan AF, et al. Acase-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14;18) translocations and bcl-2 expression. Cancer Causes Control 2010;21:1147-1154.
11. Chiu BC, Dave BJ, Blair A, et al. Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin ' s lymphoma. Am JEpidemiol 2007;165:652-659.
12. Kanda J, Matsuo K, Kawase T, et al. Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospitalbased case-control study at Aichi Cancer Center. Cancer Epidemiol Biomarkers Prev 2009;18:2436-2441.
13. Monnereau A, Orsi L, Troussard X, et al. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study. Cancer Causes Control 2008;19:1147-1160.
14. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev 2005;14:925-933.
15. Nieters A, Deeg E, Becker N. Tobacco and alcohol consumption and risk of lymphoma: results of a population-based case-control study in Germany. Int JCancer 2006;118:422-430.
16. Schollkopf C, Smedby KE, Hjalgrim H, et al. Cigarette smoking and risk of non-Hodgkin ' s lymphoma-a population-based casecontrol study. Cancer Epidemiol Biomarkers Prev 2005;14:1791-1796.
17. Stagnaro E, Tumino R, Parodi S, et al. Non-Hodgkin ' s lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13: 431-437.
18. Morton LM, Holford TR, Leaderer B, et al. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br JCancer 2003;89:2087-2092.
19. Stagnaro E, Ramazzotti V, Crosignani P, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001;12: 325-334.
20. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [website]. 2011. Available from: http://www.ohri.ca/programs/clinical+epidemiology/oxford.asp
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
22. Higgins JP,Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
23. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-463.
24. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA2000;283:2008-2012.
25. Fernberg P, Odenbro A, Bellocco R, et al. Tobacco use, body mass index and the risk of malignant lymphomas-a nationwide cohort study in Sweden. Int JCancer 2006;118:2298-2302.
26. Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin ' s lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 1998;7:25-28.
27. Lim U, Morton LM, Subar AF, et al. Alcohol, smoking, and body size in relation to incident Hodgkin ' s and non-Hodgkin ' s lymphoma risk. Am JEpidemiol 2007;166:697-708.
28. Nieters A, Rohrmann S, Becker N, et al. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition. Am JEpidemiol 2008;167:1081-1089.
29. Parker AS, Cerhan JR, Dick F, et al. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 2000;37:341-349.
30. Troy JD, Hartge P, Weissfeld JL, et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am JEpidemiol 2010;171:1270-1281.
31. Lu Y, Wang SS, Reynolds P, et al. Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study. Am JEpidemiol 2011;174:563-573.
32. Besson H, Brennan P, Becker N, et al. Tobacco smoking, alcohol drinking and non-Hodgkin ' s lymphoma: a European multicenter casecontrol study (Epilymph). Int JCancer 2006;119:901-908.
33. Cartwright RA, McKinney PA, O'Brien C, et al. Non-Hodgkin ' s lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988;12:81-88.
34. Casey R, Piazzon-Fevre K, Raverdy N, et al. Case-control study of lymphoid neoplasm in three French areas: description, alcohol and tobacco consumption. Eur JCancer Prev 2007;16:142-150.
35. De Stefani E, Fierro L, Barrios E, et al. Tobacco, alcohol, diet and risk of non-Hodgkin ' s lymphoma: a case-control study in Uruguay. Leuk Res 1998;22:445-452.
36. Fabbro-Peray P, Daures JP, Rossi JF. Environmental risk factors for non-Hodgkin ' s lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Control 2001;12: 201-212.
37. Freedman DS, Tolbert PE, Coates R, et al. Relation of cigarette smoking to non-Hodgkin ' s lymphoma among middle-aged men. Am JEpidemiol 1998;148:833-841.
38. Hardell L, Eriksson M,Degerman A. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin' s lymphoma. Cancer Res 1994;54:2386-2389.
39. Persson B, Fredriksson M, Olsen K, et al. Some occupational exposures as risk factors for malignant lymphomas. Cancer 1993;72:1773-1778.
40. Siemiatycki J, Krewski D, Franco E, et al. Associations between cigarette smoking andeach of 21 types of cancer: a multi-site casecontrol study. Int JEpidemiol 1995;24:504-514.
41. Talamini R, Polesel J, Montella M, et al. Smoking and non-Hodgkin lymphoma: case-control study in Italy. Int JCancer 2005;115: 606-610.
42. Zahm SH, Weisenburger DD, Holmes FF, et al. Tobacco and non-Hodgkin ' s lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control 1997;8:159-166.
43. Bofetta P. I. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol 2011;22(SUPPL. 4):iv27-iv31.
44. Viswanath K, Herbst RS, Land SR, et al. Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res 2010;70:3419-3430.
45. Castillo JJ, Dalia S, Shum H. Meta-analysis on the association between cigarette smoking and incidence of Hodgkin lymphoma. JClin Oncol 2011;29:3900-3906.
46. Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. JNatl Cancer Inst 1995;87:223-224.
47. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immuno globulin transcript resulting from the t(14;18) translocation. Cell 1986;47:19-28.
48. Hogan AE, Corrigan MA, O'Reilly V, et al. Cigarette smoke alters the invariant natural killer Tcell function and may inhibit anti-tumor responses. Clin Immunol 2011;140:229-235.
49. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 2008;57:497-503.
50. van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004;59:713-721.
51. Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001-2008 National Health and Nutrition Examination Survey. Med Care 2010;48:1128-1132.